The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

Dec. 11, 2019
Applicant:

Omrix Biopharmaceuticals Ltd., Rehovot, IL;

Inventors:

Inbar Gahali-Sass, Mazkeret Batya, IL;

Israel Nur, Nes-Ziona, IL;

Erez Ilan, Kibbutz Netzer Sereni, IL;

Ronen Eavri, Binyamina, IL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); A61K 38/36 (2006.01); A61K 38/48 (2006.01); A61P 41/00 (2006.01); A61K 38/37 (2006.01); A61K 9/08 (2006.01); A61P 7/04 (2006.01); A61K 33/06 (2006.01); A61K 38/38 (2006.01);
U.S. Cl.
CPC ...
A61K 38/363 (2013.01); A61K 9/08 (2013.01); A61K 33/06 (2013.01); A61K 38/366 (2013.01); A61K 38/37 (2013.01); A61K 38/38 (2013.01); A61K 38/4833 (2013.01); A61P 7/04 (2018.01); A61P 41/00 (2018.01); C12Y 304/21005 (2013.01);
Abstract

Disclosed herein is an anti-adhesion kit comprised of: (i) a fibrinogen solution component comprising: fibrinogen at a concentration of about 5 to 25 mg/ml; and free calcium ions at a concentration ranging from 0.1 μM to 1 mM; and (ii) a thrombin component containing thrombin. Further disclosed is an anti-adhesion kit comprised of: (i) a fibrinogen solution component containing fibrinogen at a concentration of 8% to 25% of total protein by weight, and optionally free calcium ions at a concentration ranging from 0.1 μM to 1 mM; wherein a total protein concentration ranges from about 80 to 120 mg/ml; and (ii) a thrombin component containing thrombin. Methods of using the kits e.g., to provide anti-adhesion curable compositions are also disclosed.


Find Patent Forward Citations

Loading…